Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease.

Trial Profile

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2018

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
  • Focus Adverse reactions
  • Acronyms DEVELOP
  • Sponsors Janssen Biotech
  • Most Recent Events

    • 03 Oct 2018 Planned primary completion date changed from 30 Jun 2038 to 15 Nov 2037.
    • 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 13 Jun 2017 Planned primary completion date changed from 31 Dec 2038 to 30 Jun 2038.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top